In Tunisia, the female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 currently stands at 11.3%, reflecting an increase of 0.1% (0.9%) since 2020.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Tunisia
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2021
Points:
13,975
Measure:
%
More indicators for Tunisia
Out-of-pocket expenditure PPP per capita
intl dollar300
+intl dollar25
(2022)
Newborns protected against tetanus
98%
0%
(2023)
Female wasting in children
2.1%
+0.3%
(2018)
Birth registration
99.9%
+0.9%
(2018)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
48.4%
+4.1%
(2023)
Tunisia Female CVD, cancer, diabetes or CRD between 2000 and 2021
| Period | Value | Change |
|---|---|---|
| 2021 | 11.3% | +0.1% |
| 2020 | 11.2% | -0.3% |
| 2019 | 11.5% | -0.2% |
| 2018 | 11.7% | -0.1% |
| 2017 | 11.8% | 0% |
| 2016 | 11.8% | -0.1% |
| 2015 | 11.9% | -0.1% |
| 2014 | 12% | -0.1% |
| 2013 | 12.1% | -0.1% |
| 2012 | 12.2% | -0.2% |
| 2011 | 12.4% | -0.3% |
| 2010 | 12.7% | -0.1% |
| 2009 | 12.8% | -0.2% |
| 2008 | 13% | -0.2% |
| 2007 | 13.2% | -0.1% |
| 2006 | 13.3% | -0.3% |
| 2005 | 13.6% | -0.2% |
| 2004 | 13.8% | -0.1% |
| 2003 | 13.9% | -0.3% |
| 2002 | 14.2% | -0.2% |
| 2001 | 14.4% | -0.2% |
| 2000 | 14.6% |